Side effects across medicines
Medicines whose labels list skin redness
576 medicines have an FDA label that names skin redness (erythema) in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of skin redness name adapalene (38,589), dupilumab (13,623) and adalimumab (7,342), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list skin redness?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 150 of the 576 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of skin redness |
|---|---|---|
| Cabazitaxel | boxed warning | none in the top 1,000 |
| Paclitaxel | precautions | 2,148 |
| Interferon beta 1a | warnings and precautions (intramuscular label) | 913 |
| Hydroxyzine | precautions | 847 |
| Levofloxacin | warnings and precautions (intravenous label) | 734 |
| Buprenorphine | warnings and precautions (subcutaneous label) | 299 |
| Promethazine | warnings (intramuscular/ | 251 |
| Tretinoin | precautions | 239 |
| Acitretin | precautions | 190 |
| Testosterone | warnings and precautions (subcutaneous label) | 177 |
| Ofloxacin | precautions (oral label) | 97 |
| Tazarotene | warnings and precautions (topical label) | 82 |
| Calcium chloride | warnings and precautions (intravenous/ | none in the top 1,000 |
| Cerliponase alfa | warnings and precautions | none in the top 1,000 |
| Dexamethasone and neomycin and polymyxin b | warnings (topical label) | none in the top 1,000 |
| Dextroamphetamine | warnings and precautions (transdermal label) | none in the top 1,000 |
| Glucagon | warnings and precautions (intravenous label) | none in the top 1,000 |
| Hyaluronidase and ocrelizumab | warnings and precautions | none in the top 1,000 |
| Hyaluronidase and rituximab | warnings and precautions | none in the top 1,000 |
| Mesna | warnings and precautions (oral label) | none in the top 1,000 |
| Palovarotene | warnings and precautions | none in the top 1,000 |
| Penicillin g benzathine and penicillin g procaine | precautions | none in the top 1,000 |
| Succimer | warnings and precautions (intravenous label) | none in the top 1,000 |
| Adapalene | adverse reactions | 38,589 |
| Dupilumab | adverse reactions | 13,623 |
| Adalimumab | adverse reactions | 7,342 |
| Prednisone | adverse reactions | 6,903 |
| Folic acid | adverse reactions | 3,566 |
| Lisinopril | adverse reactions | 2,896 |
| Methylprednisolone | adverse reactions | 2,858 |
| Dexamethasone | adverse reactions | 2,575 |
| Hydrocortisone | adverse reactions (oral label) | 2,503 |
| Omalizumab | adverse reactions | 2,394 |
| Carboplatin | adverse reactions | 2,182 |
| Dimethyl fumarate | adverse reactions | 2,133 |
| Esomeprazole | adverse reactions (intravenous label) | 2,089 |
| Tocilizumab | adverse reactions | 1,982 |
| Prednisolone | adverse reactions | 1,951 |
| Lamotrigine | adverse reactions | 1,686 |
| Fluticasone | adverse reactions (topical label) | 1,683 |
| Tofacitinib | adverse reactions | 1,611 |
| Fish oil | adverse reactions | 1,549 |
| Capecitabine | adverse reactions | 1,478 |
| Alendronate | adverse reactions | 1,393 |
| Potassium chloride | adverse reactions (intravenous label) | 1,351 |
| Certolizumab | adverse reactions | 1,301 |
| Sodium chloride | adverse reactions | 1,292 |
| Risankizumab | adverse reactions | 1,173 |
| Insulin glargine | adverse reactions | 1,153 |
| Zolpidem | adverse reactions | 1,124 |
| Glatiramer | adverse reactions | 1,078 |
| Treprostinil | adverse reactions | 1,053 |
| Vancomycin | adverse reactions | 1,031 |
| Epinephrine | adverse reactions (intramuscular/ | 1,005 |
| Tacrolimus | adverse reactions (topical label) | 1,005 |
| Estradiol | adverse reactions (transdermal label) | 1,002 |
| Fluorouracil | adverse reactions | 989 |
| Clonidine | adverse reactions (transdermal label) | 850 |
| Fentanyl | adverse reactions (transdermal label) | 849 |
| Mesalamine | adverse reactions (rectal label) | 835 |
| Ustekinumab | adverse reactions | 833 |
| Cyclophosphamide | adverse reactions | 811 |
| Adalimumab-aaty | adverse reactions | 761 |
| Adalimumab-fkjp | adverse reactions | 757 |
| Triamcinolone | adverse reactions (intra-articular/ | 756 |
| Enoxaparin | adverse reactions | 682 |
| Vedolizumab | adverse reactions | 678 |
| Botulinum toxin type a | adverse reactions | 661 |
| Dexlansoprazole | adverse reactions | 606 |
| Nivolumab | adverse reactions | 604 |
| Insulin lispro | adverse reactions | 590 |
| Iohexol | adverse reactions | 577 |
| Cetuximab | adverse reactions | 570 |
| Sorafenib | adverse reactions | 557 |
| Sunitinib | adverse reactions | 522 |
| Bimatoprost | adverse reactions | 518 |
| Duloxetine | adverse reactions | 517 |
| Evolocumab | adverse reactions | 511 |
| Aprepitant | adverse reactions (intravenous label) | 509 |
| Latanoprost | adverse reactions | 501 |
| Everolimus | adverse reactions | 488 |
| Ribociclib | adverse reactions | 467 |
| Panitumumab | adverse reactions | 456 |
| Alemtuzumab | adverse reactions | 452 |
| Fosaprepitant | adverse reactions | 451 |
| Mepolizumab | adverse reactions | 420 |
| Fulvestrant | adverse reactions | 419 |
| Moxifloxacin | adverse reactions | 419 |
| Mupirocin | adverse reactions | 418 |
| Estrogens conjugated | adverse reactions (vaginal label) | 407 |
| Ketoconazole | adverse reactions (oral label) | 388 |
| Doxorubicin | adverse reactions | 381 |
| Iopromide | adverse reactions | 381 |
| Pegfilgrastim | adverse reactions | 376 |
| Gadobutrol | adverse reactions | 373 |
| Risperidone | adverse reactions | 365 |
| Methylphenidate | adverse reactions | 356 |
| Ixekizumab | adverse reactions | 352 |
| Clotrimazole | adverse reactions | 350 |
| Insulin aspart | adverse reactions (intravenous/ | 335 |
| Belimumab | adverse reactions | 328 |
| Filgrastim | adverse reactions | 325 |
| Varenicline | adverse reactions | 324 |
| Ruxolitinib | adverse reactions (topical label) | 321 |
| Desonide | adverse reactions | 314 |
| Vemurafenib | adverse reactions | 312 |
| Selexipag | adverse reactions | 309 |
| Betamethasone | adverse reactions (intra-articular/ | 306 |
| Isotretinoin | adverse reactions | 303 |
| Telmisartan | adverse reactions | 292 |
| Alirocumab | adverse reactions | 290 |
| Bimekizumab | adverse reactions | 287 |
| Glimepiride | adverse reactions | 286 |
| Erythromycin | adverse reactions (topical label) | 274 |
| Darbepoetin alfa | adverse reactions | 266 |
| Iodixanol | adverse reactions | 265 |
| Ciprofloxacin and hydrocortisone | adverse reactions | 260 |
| Abaloparatide | adverse reactions | 255 |
| Semaglutide | adverse reactions | 252 |
| Nilotinib | adverse reactions | 243 |
| Glyburide | adverse reactions | 242 |
| Anakinra | adverse reactions | 240 |
| Sarilumab | adverse reactions | 238 |
| Calcitriol | adverse reactions (topical label) | 234 |
| Leuprolide | adverse reactions | 232 |
| Desloratadine | adverse reactions | 220 |
| Insulin human | adverse reactions (subcutaneous label) | 219 |
| Liraglutide | adverse reactions | 217 |
| Carbidopa and levodopa | adverse reactions (enteral label) | 214 |
| Perflutren | adverse reactions | 213 |
| Prochlorperazine | adverse reactions | 206 |
| Tralokinumab | adverse reactions | 206 |
| Dulaglutide | adverse reactions | 205 |
| Ertapenem | adverse reactions | 203 |
| Ioversol | adverse reactions | 202 |
| Rivastigmine | adverse reactions (transdermal label) | 201 |
| Dapsone | adverse reactions (topical label) | 190 |
| Pramipexole | adverse reactions | 189 |
| Etonogestrel | adverse reactions | 186 |
| Epoetin | adverse reactions | 183 |
| Imiquimod | adverse reactions | 183 |
| Ofatumumab | adverse reactions | 183 |
| Granisetron | adverse reactions (transdermal label) | 178 |
| Dextrose | adverse reactions | 168 |
| Dicyclomine | adverse reactions | 168 |
| Pegvaliase | adverse reactions | 168 |
| Chlorhexidine | adverse reactions (dental label) | 166 |
| Diroximel fumarate | adverse reactions | 166 |
| Erenumab | adverse reactions | 166 |
| Lamivudine | adverse reactions | 165 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most skin redness reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Erythema”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch